Search
+
    SEARCHED FOR:

    IPO SIZE

    Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscription

    Emcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO includes fresh equity shares worth Rs 800 crore and an Offer For Sale (OFS) of 1.14 crore shares. Priced at Rs 960-1,008 per share, investors can bid for 14 shares per lot. The company targets to raise Rs 1,952 crore at the upper price range.

    Bansal Wire IPO opens Wednesday: Here are 10 things to know about the public offer

    The IPO of Bansal Wire is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 745 crore through this public offering. This IPO consists entirely of a fresh equity sale of 2.91 crore shares, with no OFS component involved. According to market analysts, Bansal Wire currently commands a GMP of Rs 65 in the unlisted market.

    Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPO

    Shark Tank's Namita Thapar, who is part of Emcure Pharmaceuticals' promoter group, is set to earn approximately Rs 127 crore through the upcoming IPO. Thapar, who acquired shares in Emcure at an average price of Rs 3.44 each, will sell around 12.68 lakh shares through the OFS component of the IPO. With the upper price band set at Rs 1,008 per share, the stake sale is expected to yield about Rs 127 crore.

    Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issue

    Emcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 1,952 crore through the public offer. Market analysts indicate that the current GMP of the pharma company stands at Rs 260 in the unlisted market.

    Health insurer Niva Bupa files for Rs 3,000 crore IPO

    The company, majority owned by British United Provident Fund (Bupa), said it will issue fresh shares worth up to eight billion rupees as part of the offering.It aims to use the proceeds from that sale to strengthen its balance sheet and for operating expenses.

    Vraj Iron and Steel IPO subscribed nearly 40 times so far on last day. Check GMP and other details

    Analysts advised investors to subscribe to the Vraj Iron and Steel IPO as the company's well-established and strategically located manufacturing facilities, coupled with a focus on value-added products and ongoing expansion plans, position it for future growth. The company's shares are trading with a premium of Rs 90 in the unlisted market,

    The Economic Times
    BACK TO TOP